State Street SPDR S&P Pharmaceuticals ETF (XPH)
State Street SPDR S&P Pharmaceuticals ETF (XPH) — healthcare and biotech ETF. Analyze it on ETF Copilot.
U.S. pharmaceutical companies, focused on the core health-care economy.
A focused play on U.S. pharma — narrow exposure to a sector with persistent profitability challenges.
25% of XPH is its ten largest holdings.
Less concentrated than 83% of Healthcare & Biotech ETFs.
What's inside XPH: Size (large 10%, mid 19%, small 71%); Geography (international 8%, us 92%).
As of July 29, 2026, ETF Copilot scores State Street SPDR S&P Pharmaceuticals ETF (XPH) 2.8 out of 10 overall.
Updated July 29, 2026
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 2.8 / 10
- Growth: 0.3 / 10
- Risk: 4.4 / 10
- Profitability: 3.5 / 10
- Return: 3.8 / 10
Register free to unlock XPH's price, fees, yield, and holdings on ETF Copilot.
Register free →